lobbying_activities: 673839
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 673839 | 5702c24e-e0fa-44d6-8853-07cdaac0664d | Q3 | RASKY PARTNERS, INC. | 297410 | ELI LILLY AND CO | 2008 | third_quarter | PHA | HR 5629, Pathway for Biosimilars Act Legislation | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2008-10-17T11:57:03-04:00 |